Redwood Scientific Technologies, Inc. develops and markets homeopathic products which feature oral strip delivery technology. The company is headquartered in Albany, New York. The company went IPO on 2008-03-12. RST utilizes Patent-pending, sublingual strip delivery technology that enhances bioavailability. The main product, Prolongz, is designed to treat premature ejaculation in men. Prolongz has been registered with the FDA #079526408, allowing Redwood to elevate ourselves from competitors. Redwoods Prolongz is on course to establish ourselves as the industry leader for the adult male sexual performance dysfunction market through our membership (subscription) model. The firm is aggressively expanding our customer population through heavy investments in national cable television commercials and infomercials which also drives consumer awareness and retail sales. Source: Crunchbase
RSCI stock price ended at $0.01 on 星期三, after rising 0.00%
On the latest trading day Dec 10, 2025, the stock price of RSCI rose by 0.00%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 2.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.1K shares were traded, equating to a market value of approximately $1.9M.